← Eichor
Study identifier: NCT04537182 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Surgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema

Condition: Emphysema  ·  Sponsor: Isabelle Opitz, Professor, MD

PhaseNA
Planned participants120
Who can joinAll sexes, 30 Years to 80 Years
Healthy volunteersNo

About this study

The investigators plan to perform a randomized controlled trial that compares bilateral lung volume reduction surgery (LVRS) with bronchoscopic lung volume reduction (BLVR) using endobronchial valves in terms of efficacy and patient safety.

This description comes directly from the study's public registry record.

Talk to the study team

Isabelle Opitz, Prof. MD  ·  +41 44 255 11 11  ·  isabelle.schmitt-opitz@usz.ch

Albana Rexhepaj, PhD  ·  +41 44 255 92 30  ·  Albana.RexhepajBaumann@usz.ch

Always discuss trial participation with your own doctor first.

Locations (6)

Universitätsklinik für Thoraxchirurgie, Medical University of ViennaVienna, AustriaRecruiting
University Hospital LeuvenLeuven, BelgiumRecruiting
Rigshospitalet, University of CopenhagenCopenhagen, DenmarkRecruiting
Kantonsspital AarauAarau, Canton of Aargau, SwitzerlandRecruiting
Lausanne University Hospital (CHUV)Lausanne, Canton of Vaud, SwitzerlandRecruiting
University Hospital Zurich, Division of Thoracic SurgeryZurich, Canton of Zurich, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04537182